Ibudilast: Phase Ib started

MediciNova began a double-blind, placebo-controlled, crossover, U.S. Phase Ib trial to evaluate twice-daily 20 and 50 mg oral ibudilast for 7 days in 12 methamphetamine-dependent patients. MediciNova ...